PulmonxLUNG
Recorded

Pulmonx 2026 Stifel Healthcare Conference

Review the key takeaways and the transcript of this earnings call.

Period 2026Duration30 minParticipants2

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Rick WiseManaging Director

Ready. Hello, everybody. Rick Wise here again, and I'm pleased to welcome my guest, Glen French, Chief Executive Officer of Pulmonx. Glenn, we keep doing this, and it's great to have you back again in this seat and talk about Pulmonx. It's been a very good year since you and Derrick have returned to the company, and I think the improvement in the operating picture is very visible. Third quarter sales returned to growth in both your businesses. U.S. was up 7%, OUS up 5%. Talk about some of the changes that you've been implementing at just a high level. We'll dig into them some more, but what's changed most on the commercial execution front, and compare and contrast that with what's going on internationally?

Glen FrenchCEO

Yeah. In some ways, we can start with international. I left the company. I don't know if people know my history. I was the CEO of Pulmonx for about a decade. I retired in early 2024 and came back about 20 months later, and have been back now almost exactly one year. The last meeting that we held in Europe in early 2024, sort of the typical annual kickoff, we do a meeting in the U.S., we do a meeting for our international team, always based in Europe. We knew that we had the treating centers set up across Europe, and we really needed to focus on driving patients into those centers. So, essentially focus on same store sales and execute against that in a very focused way.

Glen FrenchCEO

We delivered 15% growth in 2024 in international business and 15% growth ex-China in our, well, that'll come up in a moment why that matters, in 2025 as well. We're off and running. If you look at our growth, again, ex-China, and that's in Europe, which is the bulk of our international business, it's far stronger. It's closer to 10%. I think it's at 9% in the quarter, and we expect to deliver double-digit growth there as well.

Glen FrenchCEO

So, we're essentially executing on. We executed on a plan of driving, focusing on driving patients that are close to the treating centers into those treating centers and making sure that the treating centers themselves were executing on bringing patients from the front door to the procedure room in a very efficient way. That's relevant because it's a pretty simple situation. You set up accounts, yet with champions and with processes that work well, and you drive patients through. You try to capture the patients that are easiest to get. So, the treating physician too often, in the past, wasn't even looking at their own patients fully.

Glen FrenchCEO

I see. Mm-hmm. They weren't going to their partners.

Glen FrenchCEO

A lot of these pulmonologists flock together at these treating centers. You might have 10, 20, 30 pulmonologists at a place like the Cleveland Clinic, and they're essentially partners in a large practice. You want to make sure that they understand this new technology and the type of patients that they should be treating. There are a spectacular number of patients with severe COPD. Some of them have emphysema and a specific distribution that's ideal for our procedure, so we want to make sure we get them. There are pulmonary function labs in these hospital systems. We're treating trapped gas. Trapped gas is diagnosed through these pulmonary function tests. We just want to make sure that we're picking the low-hanging fruit.

Glen FrenchCEO

One of the things that we had this kind of best practices established a couple years ago and executed it outside the United States. I left, and when I came back, as is sometimes the case with new people, they wanted to embrace a bunch of new things, and we weren't getting a good return on those investments.

Glen FrenchCEO

I see. There's many of which have been talked about in prior conversations with prior management.

Glen FrenchCEO

We just kind of went back to the basics. We took that playbook that I articulated relative to the European organization.

Glen FrenchCEO

Let's make sure in our case, we had 50% sales turnover, so number one, we need to fill the seats. Number two, we needed to elevate very quickly the capabilities of these new people because tenure went way down.

Glen FrenchCEO

Right Because of the loss of these folks, bring them up to speed quickly, get these centers, our best centers, make sure that they are where they need to be, and then drive patients into them.

Glen FrenchCEO

We narrowed the focus. When I came back, the last U.S. sales leadership meeting, which occurred a month or so before we decided to make the change, I remained on the board while I was Right in this intervening time.

Glen FrenchCEO

I came back and I looked at the slides from the last sales leadership meeting. They had 30 imperatives. You have 30 things you have to do as a sales organization, and I'm like, "How can anybody?

Glen FrenchCEO

Right We focus on four things now.

Glen FrenchCEO

Those are essentially around making sure that the accounts are up and running and efficient and using best practices, and then picking the low-hanging fruit as it relates to driving patients in. That's what we've been focused on. The first quarter that we were back, we bottomed out after eight consecutive successively slower growth quarters. The last five quarters we reported before Derrick and I left were average 41% growth in the U.S. That bottom-out quarter, like literally every percent change over prior quarter bottomed out at 11. It was almost a straight line. It went down. Yeah. The first up quarter was -7%, then -4%, and the last one was +7%.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

Other earnings calls that day

View calls from this day